John Vargo, MD, MPH

Appointed
1994

Education & Fellowships

Fellowship - Cleveland Clinic
Gastroenterology
Cleveland, OH USA
1990

Residency - Montefiore Hospital/Univ. Health Center of Pittsburgh
Internal Medicine
Pittsburgh, PA USA
1988

Medical Education - University of Rochester School of Medicine and Dentistry
MD
Rochester, NY USA
1985

Undergraduate - University of Rochester
Biology
Rochester, NY USA
1981

Graduate School - Case Western Reserve University
Cleveland, OH USA

Additional Training

• Master of Public Health, Case Western Reserve University, Cleveland, Ohio, 2003

Professional Highlights

• American Society for Gastrointestinal Endoscopy Career Development Award, 2003

Certifications

• Internal Medicine

Specialty Interests

advanced endoscopy, advanced imaging techniques, biliary tract disease, Capsule Endoscopy, Colonoscopy, CRCP, deep enteroscopy, deep enteroscopy and interventional endoscopy, Diagnostic and therapeutic EGD (upper endoscopy) and colonoscopy, diagnostic and therapeutic endoscopy, diagnostic/therapeutic endoscopy, diseases of the small bowel, double balloon enteroscopy, Double Balloon Enteroscopy i.e DBE ( Antegrade & Retrograde ) and Wireless Capsule Endoscopy, EMR, endoscopic mucosal ablative and resection techniques, Endoscopic Ultrasonography, Endoscopic Ultrasound, Endoscopy, Endoscopic cancer therapy, ERCP, Esophageal Cancer, EUS, gastrointestinal endoscopy, general gastroenterology, Pancreatic Cancer, pancreatic disorders, pancreaticobiliary endoscopy, Pancreatitis, stenting, therapeutic endoscopy, Therapeutic endoscopy including difficult colonoscopy and polypectomy

Awards & Honors

• University of Rochester Alumni Scholarship, University of Rochester, Rochester, N.Y., 1977-1981
• Phi Beta Kappa, University of Rochester, Rochester, N.Y., 1980 
• Nominated for application, Cecil Rhodes Scholarship, University of Rochester, Rochester, N.Y., 1980
• Marshal, commencement exercises, University of Rochester, Rochester, N.Y., 1981
• BA, summa cum laude, University of Rochester, 1981
• Health Professions Scholarship, United States Navy, 1982-1985
• Certificate of Merit, American College of Physicians, 1993
• Letter of Commendation, Office of the Attending Physician, United States Capitol, 1994
• United States Navy Commendation Medal, 1994
• Poster of Distinction Award, Digestive Disease  Week for “Nasopharyngeal Versus Transcutaneous Monitoring During ERCP,” 1998
• Poster of Distinction Award, Digestive Disease  Week for “Gastroenterologist-Administered Propofol for Therapeutic Upper Endoscopy,” 1999
• Poster of Distinction Award, Digestive Disease  Week for “Graphic Display of Respiratory Activity is Superior to Pulse Oximetry and Visual Assessment in the Detection of Respiratory Compromise During Therapeutic Upper Endoscopy,” 1999
• Reviewer citation, Gastrointestinal Endoscopy, 1999
• Recognized for editorial excellence, Gastrointestinal Endoscopy, 2001
• Teacher of the Year, Department of Gastroenterology, 2002

Innovations & Patents

• Use of capnography for patient monitoring during gastrointestinal endoscopy
• Use of computer-assisted propofol sedation for gastrointestinal endoscopy

Memberships

• American Society for Gastrointestinal Endoscopy
• American Gastroenterological Association
• American College of Gastroenterology
• American College of Physicians
• Honorary Fellow, Gastroenterology Society of Ecuador

See publications for John Vargo, MD, MPH.

(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 12/1/2020, Dr. Vargo has reported the financial relationships with the companies listed below. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Consulting and/or Speaking. Dr. Vargo receives fees of $5,000 or more per year as a paid consultant, speaker or member of an advisory committee for the following companies:

• Exact Sciences Corp.

Royalty Payments. Dr. Vargo receives or has the right to receive royalty payments for inventions or discoveries commercialized through the companies shown below:

• Medtronic plc

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.